Verona Pharma (Nasdaq: VRNA) is already recording millions of dollars in revenue after launching its lead drug in August ...

A recent study showed that the COPD assessment test was reliable and responsive for assessing health status in fibrotic ...

Q3 2024 Earnings Call Transcript November 4, 2024 Verona Pharma plc beats earnings expectations. Reported EPS is $-0.08819, ...

A recent study has linked long-term positive airway pressure therapy with improved survival in patients with COPD and ...

South Korean researchers have developed a new technology that can recognize and detect lung diseases such as Chronic ...

Verona Pharma ( (VRNA) ) has released its Q3 earnings. Here is a breakdown of the information Verona Pharma presented to its investors. Verona ...

The most common symptoms of a chest infection include a persistent cough, wheezing, breathlessness, a high temperature, ...

Two Indiana University doctors have been awarded grants by the American Lung Association Research Institute for their ...

Medicare's phased implementation of the competitive bidding program in 2011 and 2013 did not reduce oxygen use, according to the findings of a new study published in JAMA Internal Medicine.

Anyone looking for a new career could do a lot worse than getting into respiratory therapy, according to Dr. Peter Jaswilko, ...

Walking pneumonia typically attacks the ones with a weakened immune system (immunocompromised) or takes immunosuppressant ...

After Deepavali, Bengaluru faces a significant decline in air quality, leading to increased respiratory issues. Doctors ...